Cognitive Decline & Alzheimer's Prevention Treatment in Greenville, SC
Integrative approach to cognitive decline and Alzheimer's prevention in Greenville, SC. Dr. Hendry uses functional medicine testing and acupuncture to address the metabolic, hormonal, and inflammatory drivers of memory loss. Call (864) 365-6156.
What Is Cognitive Decline & Alzheimer's Prevention?
Cognitive decline — the gradual loss of memory, reasoning, language, and executive function — is not an inevitable consequence of aging. Emerging research over the past two decades has established that Alzheimer's disease and most forms of dementia have identifiable, addressable biological drivers that begin disrupting brain function decades before symptoms appear. The window for meaningful intervention is wide and early. At Integrative Health Partners, Dr. Hendry's functional medicine approach to cognitive health identifies the specific metabolic, inflammatory, hormonal, vascular, and nutritional factors that impair brain function and accelerates cognitive aging — then addresses them systematically. This is not a memory supplement protocol. It is a comprehensive biological investigation. Mild cognitive impairment (MCI) sits between normal age-related forgetfulness and diagnosable dementia — and represents the highest-leverage intervention point. Patients noticing consistent word-finding difficulty, short-term memory lapses that have worsened over months or years, or cognitive fatigue that wasn't present five years ago are the ideal candidates for this evaluation.
Common Symptoms
Root Causes: A Functional Medicine Perspective
Research from Dale Bredesen, MD (University of California) and other investigators has characterized Alzheimer's disease as a condition driven by multiple converging biological insults rather than a single-cause disease. The most clinically significant and addressable drivers include:
**Metabolic dysfunction (Type 3 Diabetes):** Insulin resistance in the brain — impaired neuronal glucose metabolism — is a central mechanism in Alzheimer's pathology. The brain becomes unable to use glucose efficiently, starving neurons of fuel. Systemic insulin resistance, measured through fasting insulin, HOMA-IR, and post-prandial glucose patterns, is one of the most modifiable risk factors for cognitive decline.
**Neuroinflammation:** Chronic systemic inflammation crosses the blood-brain barrier and activates microglia — the brain's immune cells — driving neuronal damage and amyloid accumulation. Elevated hsCRP, homocysteine, and inflammatory cytokines are measurable markers of this process. Gut dysbiosis is a major driver of neuroinflammation through the gut-brain axis.
**Hormonal decline:** Estrogen and testosterone are neuroprotective — both promote neuronal survival, reduce amyloid production, and support hippocampal function. The cognitive changes that accompany menopause and andropause are in part neurological. Thyroid hormone is also essential for neuronal maintenance; even subclinical hypothyroidism is associated with accelerated cognitive aging.
**Nutritional deficiencies:** Elevated homocysteine — driven by B12, B6, and folate deficiency, especially with MTHFR genetic variants — is one of the strongest modifiable risk factors for brain atrophy and cognitive decline. Omega-3 fatty acid deficiency impairs neuronal membrane integrity and anti-inflammatory signaling. Vitamin D deficiency is associated with neuroinflammation and Alzheimer's risk.
**Heavy metal toxicity:** Mercury accumulates in neuronal tissue and produces amyloid-like protein aggregation; the primary sources are amalgam dental fillings and high-mercury fish consumption. Aluminum has documented neurotoxicity. Testing and addressing heavy metal burden is a routine component of Dr. Hendry's cognitive evaluation.
**Sleep disruption:** The glymphatic system — the brain's waste-clearance network — operates primarily during deep sleep, clearing amyloid-beta and tau proteins from brain tissue. Chronic poor sleep or untreated sleep apnea dramatically impairs this clearance mechanism and is associated with measurably faster amyloid accumulation.
**ApoE4 genetic risk:** The ApoE4 allele increases Alzheimer's risk 3–4-fold (one copy) to 12-fold (two copies). It is present in roughly 25% of the population. ApoE4 carriers have impaired amyloid clearance, mitochondrial dysfunction, and reduced neuroinflammation resolution — all of which are addressable through targeted interventions. Knowing your ApoE status allows for risk-stratified prevention.
How We Treat Cognitive Decline & Alzheimer's Prevention at IHP
Dr. Hendry's cognitive health evaluation begins with comprehensive functional medicine testing: fasting insulin and HOMA-IR, full thyroid panel with antibodies, sex hormone panel, homocysteine, methylmalonic acid (functional B12 status), vitamin D, omega-3 index, heavy metals panel, inflammatory markers (hsCRP, fibrinogen), complete metabolic panel, and ApoE genotyping when requested. This panel reliably identifies the biological drivers present in any individual patient — and clarifies which interventions will be most impactful.
**Metabolic optimization** targets insulin resistance through dietary modification (low-glycemic, time-restricted eating, modified Mediterranean approach), berberine supplementation for insulin sensitization, and targeted lifestyle intervention. Reversing insulin resistance is among the most powerful cognitive protective interventions available.
**Acupuncture** has documented effects on cerebral blood flow — both improving perfusion to the hippocampus and prefrontal cortex and reducing the vascular risk factors that impair brain circulation. Multiple clinical studies demonstrate acupuncture's ability to improve cognitive scores, reduce neuroinflammatory markers, and support memory consolidation. Dr. Hendry's acupuncture protocols for cognitive support include scalp acupuncture (targeting motor and memory cortex zones), distal body points that regulate the autonomic nervous system, and ear acupuncture for stress regulation.
**Chinese herbal medicine** provides some of the most clinically interesting neuroprotective agents available: Lion's Mane mushroom (Hericium erinaceus) stimulates nerve growth factor synthesis; Bacopa monnieri improves memory formation and retrieval; Ginkgo biloba improves cerebral circulation and reduces platelet aggregation; He Shou Wu (Polygonum multiflorum, processed) is used in classical Chinese medicine for age-related cognitive support. These are prescribed based on the individual patient's TCM pattern and laboratory findings, not as generic memory supplements.
**Hormonal optimization** addresses estrogen and testosterone decline with bioidentical hormone approaches when indicated; thyroid optimization using more clinically precise targets than standard labs provide; and adrenal support for cortisol dysregulation that disrupts hippocampal function and accelerates memory decline.
**Nutritional supplementation** is evidence-directed: homocysteine reduction with methylated B vitamins (methyl-B12, methylfolate, P5P), omega-3 supplementation to target an omega-3 index above 8%, vitamin D optimization, and magnesium threonate specifically for its ability to cross the blood-brain barrier and support synaptic density.
Dr. Hendry's Approach
Cognitive decline is the health concern I see patients most reluctant to address directly — partly because fear of what they might find, and partly because conventional medicine has told them nothing can be done. Both assumptions are worth questioning. Functional medicine evaluation of cognitive health in a 55-year-old is not about diagnosing Alzheimer's — it's about finding the modifiable factors already present that are either accelerating or preventable. In practice, almost every patient who comes in with cognitive concerns has at least two or three addressable drivers: elevated homocysteine from an MTHFR variant nobody ever tested for, subclinical hypothyroidism that the TSH alone missed, blood sugar dysregulation that manifests as afternoon brain fog, sleep disruption from undiagnosed apnea, or a mercury burden from thirty years of amalgam fillings. These are not philosophical concepts — they show up on testing. The Bredesen Protocol has brought important attention to the multi-driver nature of Alzheimer's disease. My clinical approach reflects the same framework: identify the specific biological insults present in this individual patient, address them in priority order, and monitor the response. There is no single protocol that applies to every person — the value is in the evaluation.